GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (NYSE:DVA) » Definitions » Enterprise Value

DaVita (DaVita) Enterprise Value : $22,315 Mil (As of Apr. 26, 2024)


View and export this data going back to 1995. Start your Free Trial

What is DaVita Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, DaVita's Enterprise Value is $22,315 Mil. DaVita's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $1,576 Mil. Therefore, DaVita's EV-to-EBIT ratio for today is 14.16.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, DaVita's Enterprise Value is $22,315 Mil. DaVita's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $2,321 Mil. Therefore, DaVita's EV-to-EBITDA ratio for today is 9.61.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, DaVita's Enterprise Value is $22,315 Mil. DaVita's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $12,140 Mil. Therefore, DaVita's EV-to-Revenue ratio for today is 1.84.


DaVita Enterprise Value Historical Data

The historical data trend for DaVita's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Enterprise Value Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20,870.21 25,268.26 24,174.11 19,764.17 21,717.20

DaVita Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19,764.17 20,088.23 21,920.46 20,928.75 21,717.20

Competitive Comparison of DaVita's Enterprise Value

For the Medical Care Facilities subindustry, DaVita's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Enterprise Value distribution charts can be found below:

* The bar in red indicates where DaVita's Enterprise Value falls into.



DaVita Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

DaVita's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

DaVita's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DaVita  (NYSE:DVA) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

DaVita's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=22315.207/1575.645
=14.16

DaVita's current Enterprise Value is $22,315 Mil.
DaVita's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,576 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

DaVita's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=22315.207/2321.088
=9.61

DaVita's current Enterprise Value is $22,315 Mil.
DaVita's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,321 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

DaVita's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=22315.207/12140.147
=1.84

DaVita's current Enterprise Value is $22,315 Mil.
DaVita's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12,140 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DaVita Enterprise Value Related Terms

Thank you for viewing the detailed overview of DaVita's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (DaVita) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Executives
Christopher Michael Berry officer: Chief Accounting Officer C/O SONDER HOLDINGS INC., 101 15TH ST., SAN FRANCISCO CA 94103
Kathleen Alyce Waters officer: Chief Legal Officer C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202
Wendy Lee Schoppert director 6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442
Phyllis R Yale director
Javier Rodriguez officer: Chief Executive Officer, DKC 601 HAWAII ST., EL SEGUNDO CA 90245
Barbara J Desoer director CITIGROUP INC., 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10013
James O Hearty officer: Chief Compliance Officer 2000 16TH STREET, DENVER CO 80202
Charles Berg director, officer: Executive Chair, DMG 48 MONROE TURNPIKE, TRUMBULL CT 06611
John M Nehra director 1119 ST PAUL ST, BALTIMORE MD 21202
Adam H Schechter director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Michael David Staffieri officer: Chief Operating Officer, DKC 2000 16TH STREET, DENVER CO 80202
Jason M. Hollar director 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Paula A Price director ONE CVS DRIVE, WOONSOCKET RI 02895
Pamela M Arway director 601 HAWAII ST., EL SEGUNDO CA 90245
Gregory J. Moore director 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601

DaVita (DaVita) Headlines

From GuruFocus

Q1 2020 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2022 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2023 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2020 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2022 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2021 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2019 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2021 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024